Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases
Majority of Invasive Bladder Cancer Patients Do Not Receive Full Recommended Care
Pertuzumab Delays Progression In HER2-Positive Breast Cancer
Sentinel Lymph Node Excision Has No Impact on Survival
Increased Breast Density Can Lead to Higher Risk
Computer Interpretation Software Does Not Improve Detection
Bone Marrow Transplant Survival Has Doubled In Young Patients
Two Studies Demonstrate Molecule Blocking Cell Damage
Interim Analysis Suggests Paclical Can Reduce Blood Levels
Hormone Therapy Can Reduce Survival In Men With Heart Problems
Zometa Can Reduce Risk Of Skeletal-Related Events
Cell Phone Radiation Does Not Raise Child’s Risk of Tumors
Clinical Trials Approved by NCI CTEP Last Month
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- A new AI tool enables speedy use of ASCO guidelines, eliminating typical errors
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
